Caroline Cromwell, MD

Clinical Focus

• Anemia
• Bone Marrow Biopsy
• Coagulation Disorders
• Hemochromatosis
• Iron-Deficiency Anemia
• Pulmonary Embolism

• Anemia
• Bone Marrow Biopsy
• Coagulation Disorders
• Hemochromatosis
• Iron-Deficiency Anemia
• Pulmonary Embolism

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, 3rd Floor, New York, NY, 10029

212-241-6756

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:10

Article:11

Review Article:2

Letter:3

Chapter:2

Recent Artifacts

• Impact of anticoagulation prior to COVID-19 infection: A propensity score-matched cohort study
• The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis
• Application of phospho-CyTOF to characterize immune activation in patients with sickle cell disease in an ex vivo model of thrombosis
• Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial
• Hematologic Changes in Pregnancy
• Whole-exome sequencing in evaluation of patients with venous thromboembolism
• Peri-operative management of heparin-induced thrombocytopenia syndrome in a patient with a suspected gynecologic malignancy
• Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura
• Myocardial infarction in a young man receiving chemotherapy for acute lymphoblastic leukemia
• Acquired hemophilia presenting as profound hematuria: Evaluation, diagnosis, and management of elusive cause of bleeding in the emergency department setting

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Cromwell did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.